- Higher certainty for generating the targeted-specific antibodies
- Selective blocking of a single target among closely related ensemble of targets, which allows:
1. Specific and exclusive blocking of ligand/receptor binding domain, aiming to increase response rate among patients.
2. Eliminating binding of conflicting ligands/receptors such as inhibitory versus activatory modulators typical to immune checkpoint functions.